{"id":"NCT01080261","sponsor":"Boston Scientific Corporation","briefTitle":"PROMUS Element Japan Small Vessel Trial","officialTitle":"A Prospective Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of a Small Vessel De Novo Coronary Artery Lesion in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2011-03","completion":"2012-12","firstPosted":"2010-03-04","resultsPosted":"2012-04-12","lastUpdate":"2016-03-29"},"enrollment":60,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Atherosclerosis","Coronary Artery Disease"],"interventions":[{"type":"DEVICE","name":"PROMUS Element","otherNames":[]}],"arms":[{"label":"PROMUS Element","type":"EXPERIMENTAL"}],"summary":"A non-randomized, small vessel (SV) trial at approximately 15 sites in Japan to enroll 60 patients with a de novo lesion ≤28 mm in length (by visual estimate) in a native coronary artery ≥2.25 mm to \\<2.50 mm in diameter (by visual estimate). Approximately thirty patients will be randomly assigned to the angiographic subset to also undergo angiographic assessment after the 12-month clinical follow-up.","primaryOutcome":{"measure":"Major Adverse Cardiac Events (MACE) (Percentage of Participants With an Event)","timeFrame":"9 months","effectByArm":[{"arm":"PROMUS Element","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":26},"locations":{"siteCount":15,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":60},"commonTop":["Nasopharyngitis"]}}